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Abscess formation and empyema are serious sequelae of pneumonia. Colonisation of the
pleural fluid occurs most frequently by aerobic organisms or mixed aerobic and anaerobic
species including: Streptococcus pneumoniae, Streptococcus milleri, Bacteroides species
and anaerobic fusobacteria. Actinomyces, Eikenella corrodens and Nocardia species are
a rarely reported combination of anaerobic organisms resulting in empyema, especially in
the Northern hemisphere. A 65-year-old man presented in a severely debilitated state with
poor dentition and features of severe pneumonia. His past medical history included diabetes
mellitus, peripheral vascular disease and cerebrovascular events. CT scan revealed consolida-
tion, empyema and abscess formation. The patient was initially managed with intravenous
dicloxacillin and metronidazole and a diagnostic aspirate was followed by chest drain
insertion. Microscopy results showed Nocardia and antimicrobial therapy was altered to co-
trimoxazole and ticarcillin/clavulanate. After additional nutritional support the patient was
fit for video assisted thoracoscopy and decortication. Further culture results confirmed the
growth of Actinomyces species and Eikenella corrodens and the therapy was modified to co-
trimoxazole and benzylpenicillin. Pneumonia and empyema due solely to anaerobic organisms
is rare but should be suspected if clinical onset is insidious. Anaerobic culture of specimens is
indispensable to the rapid choice of appropriate antibiotic.
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Abscess formation and empyema are two sequelae of
pneumonia which are found with higher frequency in the
context of obstructive bronchial carcinoma and aspiration
pneumonia. In these instances, colonisation is often by
mixed flora and may include Streptococcus pneumoniae,
Streptococcus milleri, Bacteroides species and anaerobicights reserved.
Unusual case of empyema 37fusobacteria. Investigation comprises obtaining samples by
aspiration or biopsy for careful bacteriological staining and
culture, allowing selection of the most effective antibiotic
regimen. Surgical drainage of empyema is usually required
and occasionally, decortication may also be necessary. We
report an unusual case of pneumonia resulting in an abscess
and empyema caused by Actinomyces, Eikenella corrodens
and Nocardia species.
Case report
A 65-year-old male, originally from Scotland, presented to
a regional hospital with 1e2 weeks of increasing shortness
of breath, shivers, sweats and left-sided pleuritic chest
pain. This was on a background of about 6 months of cough
productive of purulent sputum, weight loss and general
reduction in functioning. Past medical history included
insulin dependent diabetes mellitus, peripheral vascular
disease with a femoro-popliteal by-pass, and cerebrovas-
cular disease with 3 previous cerebrovascular accidents
(CVA). The most recent CVA had occurred 2 years previously
and had left him with reduced mobility due to a residual
mild right hemiparesis. He was an ex-smoker with a 100
pack-year history and had a small degree of asbestos
exposure during his career as a marine engineer.
On examination, he was apyrexial, haemodynamically
stable and saturating at 99% on 2 l of oxygen via nasal
cannulae. He had a widespread maculopapular rash with
pustules and excoriations. Examination of the respiratory
system revealed dullness to percussion and coarse crackles
at the left lung base and mid-zone. There was otherwise
normal air entry throughout.
Investigations revealed a normocytic anaemia (Hb 85 g/L),
leucocytosis with predominant neutrophilia (25.9 106 and
23.1 106 respectively) and significant thrombocytosis
(1.18 106). The CRP was elevated at 262 as was the ESR at
102 and albumin was low at 15 g/l. Liver enzymes and renal
function were normal. The chest X-ray demonstrated almost
complete ‘white-out’ of the left lung field consistent with
significant fluid collection. A CT scan of the chest confirmed
the presence of a thick-walled fluid collection involving most
of the left hemithorax and left lower-lobe consolidation
(Fig. 1).Figure 1 CT scan slice showing thick-walled empyema with
left lower-lobe consolidation.A diagnostic aspirate was performed and foul-smelling
purulent material was collected followed by insertion of an
intercostal catheter. Approximately 2 l of purulent fluid
were drained over the next 48 h. Intravenous dicloxacillin
and metronidazole were commenced whilst awaiting
bacteriology results. Gram-staining revealed the presence
of gram-negative bacilli and weakly ZN-positive branching
rods consistent with Nocardia. At this stage the antibiotic
regimen was altered to co-trimoxazole and ticarcillin/
clavulanate. The patient underwent a CT head which
revealed cerebrovascular disease only and the patient was
transferred to our centre for further investigation and
management.
On arrival at our centre we noted extreme cachexia,
debilitation, grade III/IV pressure sores involving both heels
and gross malnutrition as evidenced by severe hypo-
albuminaemia. His dentition was in an extremely poor
state e he had not had a dental review for a number of
years. Further questioning revealed a minimal oral intake
for the preceding 6e12 months, very little mobilization and
repeated refusals to attend for a medical review when
encouraged by his partner. All these issues were addressed
as part of his medical care. Thoracic surgeons were con-
sulted to give advice on the most appropriate timing for
surgical intervention and it was felt that improving his
nutritional status was the most important immediate step.
This was undertaken via enteral feeding with high protein
and high caloric feeds.
He was finally stable enough to undergo video assisted
thoracoscopy and decortication about 5 weeks after initial
presentation. Modified barium swallow demonstrated
penetration of food bolus into the upper airway. Further
culture results confirmed growth of Actinomyces sp. and
E. corrodens.Nocardiawas not isolated in culture. Antibiotic
therapy was further altered to comprise co-trimoxazole and
benzylpenicillin.
The patient recovered well and was discharged home 10
weeks post-presentation on a course of oral penicillin.Discussion
This case presents an unusual cause of empyema in the
context of extreme debilitation. The organisms isolated
have only rarely been reported to cause significant lung
pathology in such a combination.
Actinomyces species are facultatively anaerobic, gram-
positive prokaryotic bacteria and are commensals of the
human oropharynx, gastrointestinal tract and female
genitalia. There are 14 species that have been character-
ized. These include six species that have been shown to be
pathogenic in humans (Actinomyces israelii, Actinomyces
meyeri, Actinomyces odontolyticus, Actinomyces nae-
slundi, Actinomyces viscosus and Actinomyces gereneser-
iae). A. israelii is the most commonly reported species with
A. meyeri infections having a propensity for lung tissue.1
Pulmonary actinomycosis is a rare infection with an inci-
dence of 1:300,000 per year worldwide with males more
often affected than females.2,3
Most Actinomyces infections are polymicrobial with
reported co-infections of Actinobacillus actinomycetem-
comitans, E. corrodens, Enterobacteriacae, Bacteroides,
38 R.A. Seville et al.Capnocytophaga, Staphylococci, and Streptococci with
prevalence depending on site of infection.1 It has been
suggested that these other organisms may enhance the
pathogenicity of Actinomyces by creating an anaerobic
environment in which it may thrive.4
E. corrodens is a facultatively anaerobic, gram-negative
fastidious bacillus, which was first isolated by Eiken in 1958
from human saliva.5 It is a commensal bacterium of human
mucosa in the oral cavity, the upper respiratory, gastroin-
testinal and genitourinary tracts.6 Pulmonary infections of
Actinomyces and E. corrodens have similar risk factors
including alcoholism, poor oral hygiene and dental disease,
emphysema, chronic bronchitis and bronchiectasis,7 head
and neck neoplasia, diabetes mellitus, cerebrovascular
accidents, steroid use, and abuse of amphetamines.8,9
Nocardia species are aerobic branching filamentous
gram-positive, weakly acid-fast bacteria normally residing
as soil saprophytes. Inhalation of the bacilli leads to
pulmonary infection and although uncommon, causes
a serious pneumonia especially in the immunocompromised
host.10,11
The pathogenesis of the pulmonary infection caused by
Actinomyces and E. corrodens most likely starts with aspi-
ration of oropharyngeal or gastrointestinal secretions into
the lungs causing occlusion, atelectasis and pneumonitis.
The established acute inflammation is then followed by
a chronic, indolent phase with necrosis, fibrosis and cavi-
tation.4 The clinical picture of these pulmonary infections
is of pneumonia with cough and sputum, chest pain, dysp-
noea, haemoptysis and occasionally a localized chest wall
swelling. Systemic symptoms include anorexia, weight loss,
malaise, night sweats and fever.12,13 Complications repor-
ted include empyema,14 necrotic parenchymal disease,15
pseudotumor16 and bronchopleural cutaneous fistula.17 The
peak incidence is around 50 years of age for Actinomyces
and E. corrodens infections.2,3,14 In immunocompromised
patients the incidence of Actinomycosis is similar but there
appear to be two peaks of E. corrodens infections at 0e14
years and 44þ years old.8
Frequent misdiagnosis and delayed diagnosis are due in
part to actinomycosis sharing clinical features with more
common lung diseases including malignancy, tuberculosis,
fungal infections and lung abscesses.12 One study showed
that only 7% of those with the infection were suspected of
the diagnosis on admission.18 Actinomyces species are not
usually recovered from sputum or broncholavage samples
as these are not routinely anaerobically cultured. Even
anaerobic cultures may not yield positive results due to
inadequate technique, previous antibiotic therapy or
bacterial overgrowth.2 E. corrodens may also go unnoticed
in routine bacteriological tests as special laboratory
techniques and precautions are required to isolate this
bacterium.19 On gram-stain, Nocardia can be
indistinguishable from Actinomyces species, and must be
differentiated by the use of a modified acid-fast stain.20
Ultimately, CT or ultrasound guided fine needle aspiration
or core biopsy is required to provide microbial and histology
specimens to confirm diagnosis.
Clinical experience rather than randomized, controlled
trials dictates the current excepted penicillin regimen in the
treatment of Actinomyces infections21 with tetracyclines or
erythromycin as alternatives.12 E. corrodens has shownunusual antimicrobial sensitivity and variability amongst
strains. The most effective agents are penicillins,8 chlor-
amphencol and tetracycline,22 3rd generation cephalospo-
rins,23 carbapenems and quinolones.9 Studies have
demonstrated a resistance to macrolides,24 metronidazole,
cephalothin and cefuroxime9 and clindamycin.23 One group
has reported that growth of E. corrodensmaybe enhanced by
clindamycin.25 Current opinion for treatment of Nocardia
species is sulphonamides or trimethoprimesulfamethoxazole
as first line and amikacin, carbapenems and 3rd generation
cephalosporins as second line or in the severely ill as
a combination therapy.10 Surgery is an important adjunct to
medical therapy especially in cases of empyema,abscessesor
sinus infection.26e28
Our case represents a rare case of Actinomyces, E. cor-
rodens and Nocardia polymicrobial pneumonia, with
resulting complications of empyema and pulmonary
abscess. The course of events leading to this patient’s
illness in all probability began with his stroke resulting in
dysphagia and inhalation of oral secretions. With respect to
his poor dentition, oral pathogens were the most likely
candidates for infection and Actinomyces species and
E. corrodens were isolated. Delay in seeking medical care
resulted in progression of the infection, leading to severe
systemic symptoms and complications of pneumonia. This
also resulted in delaying the definitive treatment of
empyema which remains drainage and decortication.27,28
Nevertheless, good clinical care with appropriate antibiotic
use resulted in a successful treatment outcome.
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